Doris G Leung1,2, Xin Wang3, Peter B Barker4, John A Carrino5, Kathryn R Wagner1,2,6. 1. Center for Genetic Muscle Disorders, Hugo W. Moser Research Institute at Kennedy Krieger Institute, 716 North Broadway, Room 411, Baltimore, Maryland, 21205, USA. 2. Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. 3. Department of Radiation Oncology, University of Nebraska Medical Center, Omaha, Nebraska, USA. 4. Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. 5. Department of Radiology and Imaging, Hospital for Special Surgery, New York, New York, USA. 6. Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Abstract
INTRODUCTION: Facioscapulohumeral muscular dystrophy (FSHD) is a hereditary disorder that causes progressive muscle wasting. This study evaluates the use of proton magnetic resonance spectroscopy (1 H MRS) as a biomarker of muscle strength and function in FSHD. METHODS: Thirty-six individuals with FSHD and 15 healthy controls underwent multivoxel 1 H MRS of a cross-section of the mid-thigh. Concentrations of creatine, intramyocellular and extramyocellular lipids, and trimethylamine (TMA)-containing compounds in skeletal muscle were calculated. Metabolite concentrations for individuals with FSHD were compared with those of controls. The relationship between metabolite concentrations and muscle strength was also examined. RESULTS: The TMA/creatine (Cr) ratio in individuals with FSHD was reduced compared with controls. The TMA/Cr ratio in the hamstrings also showed a moderate linear correlation with muscle strength. DISCUSSION: 1 H MRS offers a potential method of detecting early muscle pathology in FSHD prior to the development of fat infiltration. Muscle Nerve 57: 958-963, 2018.
INTRODUCTION: Facioscapulohumeral muscular dystrophy (FSHD) is a hereditary disorder that causes progressive muscle wasting. This study evaluates the use of proton magnetic resonance spectroscopy (1 H MRS) as a biomarker of muscle strength and function in FSHD. METHODS: Thirty-six individuals with FSHD and 15 healthy controls underwent multivoxel 1 H MRS of a cross-section of the mid-thigh. Concentrations of creatine, intramyocellular and extramyocellular lipids, and trimethylamine (TMA)-containing compounds in skeletal muscle were calculated. Metabolite concentrations for individuals with FSHD were compared with those of controls. The relationship between metabolite concentrations and muscle strength was also examined. RESULTS: The TMA/creatine (Cr) ratio in individuals with FSHD was reduced compared with controls. The TMA/Cr ratio in the hamstrings also showed a moderate linear correlation with muscle strength. DISCUSSION: 1 H MRS offers a potential method of detecting early muscle pathology in FSHD prior to the development of fat infiltration. Muscle Nerve 57: 958-963, 2018.
Authors: Hee Kyung Kim; Tal Laor; Paul S Horn; Judy M Racadio; Brenda Wong; Bernard J Dardzinski Journal: Radiology Date: 2010-06 Impact factor: 11.105
Authors: H E Kan; D W J Klomp; M Wohlgemuth; I van Loosbroek-Wagemans; B G M van Engelen; G W Padberg; A Heerschap Journal: NMR Biomed Date: 2010-07 Impact factor: 4.044
Authors: Beatrijs H Wokke; Clemens Bos; Monique Reijnierse; Carla S van Rijswijk; Holger Eggers; Andrew Webb; Jan J Verschuuren; Hermien E Kan Journal: J Magn Reson Imaging Date: 2013-01-04 Impact factor: 4.813
Authors: Jean K Mah; Lawrence Korngut; Kirsten M Fiest; Jonathan Dykeman; Lundy J Day; Tamara Pringsheim; Nathalie Jette Journal: Can J Neurol Sci Date: 2016-01 Impact factor: 2.104
Authors: Rebecca J Willcocks; William D Rooney; William T Triplett; Sean C Forbes; Donovan J Lott; Claudia R Senesac; Michael J Daniels; Dah-Jyuu Wang; Ann T Harrington; Gihan I Tennekoon; Barry S Russman; Erika L Finanger; Barry J Byrne; Richard S Finkel; Glenn A Walter; H Lee Sweeney; Krista Vandenborne Journal: Ann Neurol Date: 2016-02-19 Impact factor: 10.422
Authors: Ishu Arpan; Rebecca J Willcocks; Sean C Forbes; Richard S Finkel; Donovan J Lott; William D Rooney; William T Triplett; Claudia R Senesac; Michael J Daniels; Barry J Byrne; Erika L Finanger; Barry S Russman; Dah-Jyuu Wang; Gihan I Tennekoon; Glenn A Walter; H L Sweeney; Krista Vandenborne Journal: Neurology Date: 2014-08-06 Impact factor: 9.910
Authors: Ishu Arpan; Sean C Forbes; Donovan J Lott; Claudia R Senesac; Michael J Daniels; William T Triplett; Jasjit K Deol; H Lee Sweeney; Glenn A Walter; Krista Vandenborne Journal: NMR Biomed Date: 2012-10-09 Impact factor: 4.044
Authors: Ivica Just Kukurová; Ladislav Valkovič; Jozef Ukropec; Barbora de Courten; Marek Chmelík; Barbara Ukropcová; Siegfried Trattnig; Martin Krššák Journal: NMR Biomed Date: 2015-11-29 Impact factor: 4.044